Funded Biotech startups in Massachusetts
49 biotech startups in Massachusetts have filed a Form D with the SEC and together report $1.66B raised. AdvanCell has the largest latest round, at $218.3M. Amounts are as reported on the filing, not estimates.
Updated Oct 7, 2026
- Companies
- 49
- Total raised
- $1.66B
- Filings
- 63
- Median round
- $7.6M
- Cities
- 22
CompanyCityLast filingLatest round
AxelyfRNA medicines for solid tumors and autoimmune disease
Chestnut Hill
Oct 7, 2026
$2.6M
ArkeaBioVaccine that cuts methane emissions from cattle
Charlestown
Sep 28, 2026
$15.0M
NextPoint TherapeuticsAntibodies against the B7-H7 checkpoint in cancer
Cambridge
Jul 22, 2026
$33.7M
Cue BiopharmaBiologics that modulate disease-specific T cells
Boston
Jul 13, 2026
$50.0M
AdvanCellLead-212 alpha therapies for prostate and other cancers
Cambridge
Jun 30, 2026
$218.3M
Qlaris BioEye drops that lower eye pressure in glaucoma
Dedham
Jun 12, 2026
$3.9M
X1 BiotechRUNX1 inhibitor for inherited small-vessel brain disease
Needham
May 20, 2026
$40K
Portal BiotechnologiesMechanical cell delivery for RNA and gene editors
Arlington
May 15, 2026
$9.0M
Remedium BioDose-adjustable gene therapy for obesity and osteoarthritis
Needham
May 6, 2026
$1.5M
Climb BioB-cell depleting antibodies for autoimmune disease
Wellesley Hills
Apr 29, 2026
$110.1M
AxoftSoft-material brain implants for stable neural recording
Cambridge
Apr 22, 2026
$34.2M
Enveric BiosciencesNon-hallucinogenic neuroplasticity drugs for depression
Cambridge
Apr 17, 2026
$5.0M
Alloy TherapeuticsTransgenic mice for human antibody discovery
Waltham
Mar 31, 2026
$30.0M
Stipple BioCancer drugs aimed at tumor-specific cell surface markers
Cambridge
Mar 31, 2026
$65.1M
PulmatrixInhaled dry powder drugs for migraine and lung disease
Framingham
Mar 26, 2026
$1.0M
Canal BiosciencesSequencing library prep that keeps native DNA ends intact
Lowell
Mar 18, 2026
$2.3M
AptaminoOral delivery of antibody drugs via protein design
Cambridge
Mar 17, 2026
$8.0M
PacegenixProdrugs for atrial fibrillation and fast heart rates
Cambridge
Mar 11, 2026
$22.5M
Consano BioBiologic therapies for orthopedic injuries
Burlington
Mar 6, 2026
$34.8M
Dnp TherapeuticsEarly-stage therapeutics company based in Cambridge…
Cambridge
Mar 5, 2026
$470K
Vaxess TechnologiesDissolvable microarray patches for vaccines
Cambridge
Mar 4, 2026
$57.3M
Inflammasome TherapeuticsInflammasome inhibitor implants for geographic atrophy
Newton
Feb 27, 2026
$13.2M
Entact BioOral drugs that enhance proteins instead of blocking them
Watertown
Jan 8, 2026
$10.0M
HolobiomeGut bacteria probiotics aimed at depression
Boston
Dec 24, 2025
$10.0M
Medici TherapeuticsTumor-infiltrating lymphocyte cell therapy for cancer
Boston
Nov 20, 2025
$14.8M
Phio PharmaceuticalsImmune-modulating cancer drugs in clinical trials
Marlborough
Nov 4, 2025
$1.4M
GelMEDIXHydrogel-delivered cell therapy for geographic atrophy
Cambridge
Oct 1, 2025
$747K
Nirrin TechnologiesLaser spectroscopy for real-time bioprocess measurement
Billerica
Sep 23, 2025
$6.7M
Dewpoint TherapeuticsSmall-molecule drugs that target biomolecular condensates
Boston
Sep 9, 2025
$77.2M
Tinos TherapeuticsRNA-targeted small-molecule drugs for glioblastoma
Cambridge
Sep 4, 2025
$2.3M
Lapix TherapeuticsOral drugs that restore immune tolerance in autoimmunity
Boston
Jul 21, 2025
$2.2M
NeutrolisEnzymes that clear neutrophil traps in autoimmune disease
Cambridge
Jun 20, 2025
$3.5M
Syntis BIOOral pill that mimics gastric bypass for weight loss
Boston
Jun 17, 2025
$25.0M
Odyssey TherapeuticsTranscription factor drugs for autoimmune disease
Boston
Jun 16, 2025
$214.0M
PhASTSingle-cell imaging for fast antibiotic susceptibility tests
Boston
Apr 11, 2025
$3.5M
Ernexa TherapeuticsOff-the-shelf stem cell therapy for ovarian cancer
Cambridge
Mar 31, 2025
$7.2M
DeepkinetiXAI pharmacokinetic modeling for drug dosing
Cambridge
Mar 3, 2025
$1.0M
Lyora TherapeuticsClinical-stage biotechnology company dedicated to developing…
Belmont
Feb 25, 2025
$525K
Newleos TherapeuticsDrugs for anxiety and substance use disorders
Boston
Feb 10, 2025
$93.4M
Tectonic TherapeuticProtein drugs targeting G protein-coupled receptors
Watertown
Feb 5, 2025
$185.0M
seqWellDNA library prep for high-throughput sequencing
Beverly
Jan 15, 2025
$12K
CarnaSmall-molecule drug discovery
Boston
Jan 3, 2025
$9.1M
TellBioMicrofluidic capture of circulating tumor cells from blood
Andover
Sep 4, 2024
$1.0M
3X GeneticsLong-read tests for repeat expansion genetic disorders
Worcester
Aug 5, 2024
$3.2M
Third PolePortable, tankless inhaled nitric oxide therapy
Waltham
Mar 18, 2024
$16.9M
AlzheonOral Alzheimer's drug targeting amyloid oligomers
Framingham
Feb 27, 2024
$126.3M
Modulate BioSmall-molecule drugs for essential tremor and epilepsy
Allston
Feb 11, 2024
$785K
Porosome TherapeuticsTherapies that restore the cell's secretory machinery
Boston
Sep 8, 2023
$3.6M
Pinteon TherapeuticsAntibody against toxic tau for brain injury and Alzheimer's
Newton Centre
Jan 7, 2022
$29.2M
All 49 companies · most recent filing first
Most recent filings
49All 49 companies · most recent filing first